Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 27G vitrectomy on ocular surface
ChiCTR2100044136Phase 4Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium hyaluronate and diquafosol in dry eye syndrome (DED) and ocular surface disease (OSD) (4 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: Visual acuity, Ocular surface analyzer parameters and 3 more. Started Mar 2021; status: recruiting.
02
Drugs
sodium hyaluronatediquafosol
03
Conditions
dry eye syndrome (DED)ocular surface disease (OSD)
Beyond the preview
Go deeper on ChiCTR2100044136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044136.